Haematological Scientific Center Russian Academy
of Medical Science Novosykovsky pr. 4a 125167 Moscow, Russia
The hematopoietic system is created by hierarchical progression
of commitment events starting from the primitive hematopoietic stem
cell (HSC). By strict definition, the primitive HSC is the founder
cell for the entire hematopoietic system, i.e. it is capable of
long-term support of hematopoiesis both in vivo and in vitro. It
is generally assumed that the primitive HSC has the capacity both
for differentiation and self-renewal (Chertkov, Gurevitch, 1984)
Nevertheless, crucial question about capacity of HSC for inexhaustible
proliferation remains unanswered Many attempts to prove unlimited
proliferative capacity of HSC by bone marrow cell passages always
demonstrated the exhaustion of HSC potential after 3-5 transfers
(Micklem et al, 1987). However, the technical reservation prevented
from getting the conclusive evidence of inability of HSC to maintain
itself. There is the other way to answer this intriguing question.
if the founder cell has the capacity for self-renewal, hematopoiesis
would be stochastic and many primitive HSCs would be functioning
simultaneously. On the other hand, if the primitive HSC has no capacity
to self-renew, hematopoiesis would be characterised by clonal succession.
According to this model, primitive HSCs are used sequentially, one
after the other, producing clones which replace each other ( Rosendaal,
Adam, 1984). Reconstitution of irradiated mice with bone marrow
cells carrying specific markers (HSC marked by retroviral integration)
was used for characterisation of clonal succession (Williams et
al, 1984; Lemischka et al, 1986; Snodgrass, Keller, 1987; Capel
et al, 1989; Jordan, Lemischka, 1990). As a rule, after several
months of " clonal fluctuations" , monooligoclonal hematopoiesis
occurs and longevity of clone functioning can be as long as 2 5
years. In contrast, the results obtained with HSC without transduced
DNA sequences suggested that hematopoiesis is polyclonal both in
normal and reconstituted animals (Micklem et a11987; Harrisson et
al, 1978 ). Differences in experimental results concerning the clonality
of HSC may be due to the prestimulation of HSC during gene transfer
procedure with pharmacological concentrations of hematopoietic growth
factors. It is possible that all primitive HSC may be induced to
proliferate by cytokines. Furthermore, progenitors with selective
proliferative advantage could gradually replace all others, and
after a time, only this one or several cell clones will be preserved
(mono-oligoclonal hematopoiesis). In order to verify this hypothesis
and to study the possible clonal succession of HSC, the next conditions
must be realized: clonal composition of the hematopoietic system
must be studied sequentially in the same reconstituted mouse; the
method used must be very sensitive to detect a great number of simultaneously
functioning clones during clonal selection; and the method of gene
transfer without prestimulation with pharmacological concentration
of cytokines should also be used. Here all these conditions were
realized and hematopoietic cell clonal succession has been demonstrated
conclusively. The proliferative potential and proliferative activity
of more mature HSC, CFU-S-11 , in animals reconstituted both with
treated by exogenous cytokines and untreated hematopoietic cells
were characterized.
Materials and Methods
Mice. Male and female (C57BI/6 x DBA/2) F 1mice, 3-5 months-old
were used. Long-term hone marrow culture. Femoral bone marrow was
cultured in Fisher's medium supplemented with 20% of 2: 1 mixture
of horse and fetal bovine serum, 10high -6 M hydrocortisone , L-glutamine
and antibiotics as described (Chertkov et al, 1983). CFU-S-ll assay,
spleen repopulating ability and Hydroxyurea "suicide '1 of CFU-S-ll
Recipients in the spleen colony-forming (CFU-S) assay were exposed
to 1200 cGy 137 Cs irradiation (the dose rate 18 cGy/min, IPK irradiator).
The dose was delivered into two equal fractions, given 3 h apart
Irradiated female mice were injected i. v. with 1 to 4 x 10high
5 marrow from reconstituted mice. Individual macroscopic colonies
were isolated under dissection microscope 11 days later and used
both for DNA analysis and for determination of the selfrenewal capacity
(spleen repopulating ability /SRA/. number of daughter CFU-S-8 per
11-day colony). The colony cells (0.2 colony equivalent) were injected
into irradiated secondary recipients. The number of daughter colonies
were counted 8 days later and the number of colonies generated per
one CFU-S-11 was calculated. Proliferative activity of CFU-S-11
was determined by hydroxyurea (HU) suicide. Bone marrow cells from
reconstituted mice were incubated in RPMI 1640 media supplemented
with 5% fetal bovine serum for 2 hours at 37oC with and without
1 mg/ml HU, washed trice with Hanks' balanced salt solution (HESS)
and injected ( 1-2 x 10 high 5) into irradiated recipients Number
of spleen colonies was determined following 8 days. Suicide (Su)
was calculated by next equation:
Retroviral vector and producing cellline. GP+E86 cell line producing
a retrovirus containing human ADA cDNA was a generous gift ofD.A.
Williams. The details of the vector have been previously reported
(Luskey et al, 1992). This cell line produces virus with a titer
1 x 10 high 6 CFU/ml. One day before use for infection of HSC, flasks
with confluent producer cells were treated with 5 µg/ml of mitomycin
C at 37°C for 2.5 hours, repeatedly washed with HBSS, detached by
trypsin-EDT A and split 1 :2 in aMEM with 20% fetal bovine serum.
Bone marrow transfection. Two protocols of transfection were used.
For prestimulation, a suspension of bone marrow cells from six 5-FU
treated mice (150 mg/kg i.v., two days before cell collection),
were cultured in 0.1% gelatine-treated T-25 flasks, at 37C in 10
ml alfa MEM with 20% fetal bovine serum and rhIL-6 ( 50-100 µg/ml)
and rhSCF ( 50 µg/ml) (Protocol 1 ). In protocol 2 the similar cells
were incubated over adherent celllayer of 15 Gy irradiated 3-4 weeks
old long-term bone marrow cultures without exogenous cytokines.
Following two days prestimulated bone marrow cells were transferred
to a monolayer of producer cells in media with 4 µg/ml polybrene
and with (protocol 1) or without (protocol 2) exogenous cytokines
After 2 days of infection, the hematopoietic cells were extensively
washed from producer cells and used for reconstitution of irradiated
mice. The doses used and the number of reconstituted mice are shown
in table 1.
Table 1 Characteristics of mice reconstituted
with retrovirally marked bone marrow cells
Collection of hematopoietic cells for DNA analysis. Bone marrow
samples were obtained at different time intervals from multiple
groups of individual anaesthetized living mice in such a way to
allow recovery between sample collection. Femoral bone marrow was
aspirated by puncture through the knee joint by a syringe with a
22-gauge needle. Usually it was possible to obtain 5-15 x 10 high
6 bone marrow cells from a living mouse. Bone marrow cells from
each transplanted mouse were injected into 6 irradiated female recipients
for CFU-S and DNA analysis. Southern blot analysis. DNA from bone
marrow and individual spleen colonies was extracted, digested with
EcoR 1, electrophoresed through a 1% agarose gel, transferred to
Hybond N filter and hybridized with ADA cDNA probe, prepared from
1.2 Kb PGK-ADA fragment. Digestion with EcoR 1 permitted analysis
of individual clones of hematopoietic cells, since only one EcoRl
restriction site is present within the LTRs of the vector used.
Determination of the origin of CFU-S in reconstituted mice. Only
male mice were used as donors of bone marrow cells, recipients were
always female For identification of CFU-S origin a Y-chromosome
probe (mouse Zfy-2) was used (a generous gift from Dr. L.G. Brown)
Filters were rehybridized with this probe after stripping the ADA
probe.
Results
The efficiency of gene transfer into CFU-S-II was high, 52-83%
of CFU-S derived colonies contained the human ADA cDNA (protocol
I ). Without exogenous cytokines the efficiency of transduction
was lower, only 18-32% of CFU-S derived colonies were marked (protocol
2). In many instances, several proviral copies per genome were integrated
as demonstrated by Southern analysis (Fig. I). Transduction efficiency
into primitive HSC also appeared to be good since, as seen in table
2, marked clones were still present in CFU-S-II from mice up to
I year after reconstitution. Analysis of clonal composition of mice
reconstituted with cytokine stimulated HSC revealed that 2 and 4
months after reconstitution the integration patterns varied between
different colonies of the same mouse, implying that the progeny
of many different clones were functioning simultaneously. From 23
colonies studied in first 4 months after reconstitution 22 had different
unique markers (Table 2).
Table 2. Clonal composition of the hematopoietic
system at different times after reconstitution
with bone marrow cells prestimulated with exogenous cytokines.
These results demonstrate that multiple clones are existing early
after transplantation. However, oligo-monoclonal hematopoiesis appeared
to become established over a more prolonged period, since only 1-2
clones were observed 6-12 months after reconstitution in DNA obtained
from CFU-S derived colonies. In sharp contrast with these data were
the results obtained with bone marrow cells prestimulated on ACLs
without exogenous cytokines. No phase of polyclonal hematopoiesis
was revealed in these mice (table 3). Efficiency of gene transfer
into primitive HSC was lower and marked clones were observed only
in 25-50% of reconstituted mice in each time interval studied However,
even in first months after reconstitution only one or two marked clones
were revealed No one of detected clones persisted more than 2-3 months.
Disappearing clones were never observed again. As can be seen from
table 3, the proportion of transduced cru-s is about 10-15% of CFU-S
studied. These observations suggest that about one-tenth of all bone
marrow CFU-S are derived from marked HSC
Fig. 1 Human ADA cDNA sequence integration pattern of
primary day 11 CFU-S colonies derived from bone marrow cells prestimulated
with exogenous cytokines or with adherent cell layer. Lanes 1-7,
DNA from colonies, produced by cy1okine prestimulated cells; lanes
8-11, DNA from colonies, produced by adherent cell layer prestimulated
cells; lane 12, DNA from producer cell line GP+E86 (hADA).
Table 3 Clonal composition of hematopoietic system in different
time after reconstitution
with non-stimulated by exogenous growth factors bone marrow cells.
To confirm the donor origin of CFU-S we assessed the presence of y
-chromosome sequences in DNA obtained from spleen colonies in all
experiments. All colonies derived from reconstitution (Fig 2) Therefore,
the procedure of gene transfer both with and without exogenous cytokines
did not decrease the developmental potential of primitive HSC
Fig 2 Detection of y -chromosome sequences in CFU-S-derived
spleen colonies from female mice reconstituted with transduced male
hematopoietic cells Lanes 1-4, 6 months after reconstitution; lanes
5- 7, 12 months after reconstitution
Proliferative activity of CFU-S was studied in mice 6 months following
reconstitution (Fig 3) The results were essentially the same in
groups reconstituted by bone marrow cells transduced both with and
without exogenous cytokines prestimulation. In mice reconstituted
with large cell inoculum suicide rate was about 10%, ie CFU-S were
mainly out of cell cycle as during steady-state hematopoiesis in
normal animals Mice reconstituted with low cell dose demonstrated
significant increase of suicide which was about 20% CFU-S with integrated
human ADA cDNA had 2-fold higher suicide rate than unmarked CFU-S.
However, because of low amount of studied marked colonies (9 from
42) the difference is insignificant.
Fig 3 CFU-S suicide in mice 6 months following reconstitution.
1,2, reconstitution according protocol 1, low and large dose of
bone marrow cells, respectively; 3,4, reconstitution according protocol
2, low and large dose of bone marrow cells, respectively.
Spleen repopulating ability (SRA) of CFU-S-ll 6 and 12 months
after reconstitution was significantly decreased in all experimental
groups of mice (Fig. 4). The average number of daughter CFU-S per
11 day colony was 20-60 as compared with 150 for normal bone marrow
derived colony. In all mice reconstituted with cytokine prestimulated
cells SRA gradually decreased during 12 months. On the other hand,
two of five mice reconstituted with transduced cells without cytokine
prestimulation had higher SRA I year after reconstitution than that
after 6 months
Fig 4 Spleen repopulating ability of CFU-S-ll in individual
reconstituted mice 6 (full bars) and 12 (open bars) months after
reconstitution A, B, reconstitution according protocol 1, low and
large dose of bone marrow cells, respectively; C, D, reconstitution
according protocol 2, low and large dose ofbone marrow cells, respectively
Discussion
The results presented here demonstrate that the difference in the
developmental fate of primitive HSC, measured with traditional methods
(competitive repopulation assay, serial bone marrow passages et
al), as compared with methods of retroviral gene transfer, could
be explained by use of pharmacological doses of exogenous hematopoietic
growth factors. A combination of cytokines (IL-6 + SCF) induced
high efficiency gene transfer into HSC, what suggests that quiescent
HSC had been stimulated for proliferation. Efficiency of gene transfer
after more physiological prestimulation of HSC on irradiated ACL
of long-term bone marrow culture was significantly lower, possibly
because of low proportion of HSC that had been triggered in cell
cycle In mice reconstituted with bone marrow cells prestimulated
with exogenous growth factors, many marked clones appeared simultaneously.
Two to 4 months after reconstitution, essentially each marked CFU-S
represents an unique clone (22 of 23 colonies were represented by
unique marker). Statistically, the results indicate that in the
first months after transplantation 200-400 clones are functioning
simultaneously (confidence interval, 95%) CFU-S is a progenitor
with relatively low proliferative potential and it can produce differentiated
progeny not more than 4 -5 weeks both in vivo (Bodine et al, 1991
; Bodine et al, 1992) and in vitro (Chertkov et al, 1987) Therefore,
during 2 -4 months after reconstitution the revealed marked clones
are progeny of primitive HSC, rather than initial CFU-S Hence, many
if not all primitive HSC are proliferative at least 4 months after
transplantation During this time, selection of clonogenic progenitor(s)
with proliferative advantages is possible, and this clone(s) can
replace all others. As a result of such selection, all marked cells
would have the same unique marker Indeed, 6 -12 months after reconstitution,
hematopoiesis appeared to be oligo-monoclonal as shown here and
by others (Rosendaal, Adam, 1984;Capelet al, 1989;Limet al, 1989)
Essentially, different results were obtained after transplantation
of cells not stimulated by exogenous cytokines The efficiency of
gene transfer was significantly lower, however the system was suitable
for the study of the hematopoietic clonal composition after reconstitution.
No phase of polyclonality was observed in this model with use of
an ACL for prestimulation. From the first months after transplantation
only lor 2 marked clones have been observed. The longevity of marked
clones existence was shorter than 2 -3 months because they were
revealed only once during one year; analysis was performed each
2 -3 months. It appears that no stem cell selection took place and
hematopoiesis was maintained by clonal succession. If appear simultaneously.
Hence, the cause of peculiarity of results obtained with gene transfer
technique is the use of pharmacological concentration of exogenous
cytokines. If it is possible to avoid such stimulation of HSC and
to use a more physiological gene transfer, the same clonal succession
and limited proliferative potential of primitive HSC would be observed.
The other evidence, that transduced foreign sequences do not change
the proliferative potential of HSC, is the same SRA in marked and
non-marked colonies The clonal succession of hematopoietic cells
was also supported by the data about increase of SRA in 12 months
as compared with 6 months in the group of mice reconstituted with
the physiologically prestimulated cells (protocol 2). It is difficult
to understand how can SRA increase in the progeny of the same primitive
HSC In the case of clonal succession this effect could be explained
by replacing the clones with low proliferating potential by clones
which were less exhausted. The incapacity of primitive HSC to maintain
itself is supported by the data obtained here and earlier (Chertkov
et al, 1993 ), that after reconstitution with large cell innoculum
the proliferative potential of progenitors, as measured by SRA,
is higher than after reconstitution with low cell dose. Of course,
this could not happen if the primitive HSC has unlimited proliferative
potential Proliferative activity of CFU-S, as measured by HU suicide,
was increased only in groups reconstituted with low dose of hematopoietic
cells It is known, that clone size is bigger in animals transplanted
with low doses of bone marrow cells ( Micklem et al, 1987). The
data suggest that this increase of clone size is due at least partially
by expansion of CFU-S at the expense of increased proliferative
rate On the whole, the results support the clonal succession model
of hematopoiesis and mortal nature of primitive HSC. The data demonstrate
the possibility of using this model for the sequential study of
the clonal composition of the hematopoietic system and primitive
HSC developmental potential
Acknowledgements
The authors wish to thank Drs D. A. Williams and L.G.Brown for
generous gift of the GP+E86 (hADA) cell line and the y probe.
This study was supported in part by ISF (Soros fund) and RFFR (Russian
Fund for Fundamental Research)
References
Bodine DM, Crosier PS, Clark SC (1991) Effects of hematopoietic
growth factors on the survival of primitive stem cells in liquid
suspension culture. Blood 78:914-920
Bodine DM, Orlic a, Birkett NC, Seidel NE, Zsebo KM (1992) Stem
cell factor increases coJony-forming unit-spleen number in vitro
in synergy with interleukin-6, and in vivo in SI/Sld mice as a single
factor. Blood 79:913-920
Capel B, Hawley R, Covarrusias L, Hawley T, Mintz B (1989) Clonal
contribution of small numbers of retrovirally marked hematopoietic
stem cells engrafted in unirradiated neonatal W/W mice. Proc Natl
Avcad Sci USA 86:4564-4567
Chertkov JL, Drize NI, Gurevitch OA, Udalov GA (1983) Hemopoietic
stromal precursors in long-term culture of bone marrow I. Precursors
characteristics, kinetics in culture, and dependence on quality
of donor hemopoietic cells in chimeras. Exp Hematol 11:231-242
Chertkov JL, Gurevitch OA (1984) Hematopoietic stem cell and its
microenvironment. Moscow. Meditzina
Chertkov JL, arize NI, aeryugina El, Udalov GA (1987) Individual
clones of hemopoietic cells in murine long-term bone marrow cultures
Leukemia 1: 491-496
Chertkov II, Iiang S, Lutton JD, Harrison I, Levere Ra, Tiefenthaler
M, Abracham NG (1993) The hematopoietic stromal microenvironment
promotes retrovirus-mediated gene transfer into hematopoietic stem
cells. Stem Cells II 218-227
Jourdan CT, Lemischka IR ( 1990) Clonal and systemic analysis
of long-term hematopoiesis in the mouse. Genes Dev 4.220
Harrison DE, Astle CM, aelaittre IA (1978) Loss of proliferative
capacity in immunohemopoietic stem cells cause by serial transplantation
rather then ageing. I Exp Med 147:1526-1531
Lemischka IR, Raulet OH, Mulligan RC ( 1986) Developmental potential
and dynamic behaviour of hematopoietic stem cells. Cell 45.917-923
Lim B, Apperley JF, Orkin SH, Williams DA ( 1989) Long-term expression
of adenosine deaminase in mice transplanted with retrovirus-infected
hematopoietic stem cells Proc Nat Acad Sci USA 86 8892-8895
Luskey BD, Rosenblatt M, Zsebo K, Williams DA (1992) Stem cell
factor, interleukin3, and interleukin-6 promote retroviral-mediated
gene transfer into murine hematopoietic stem cells Blood 80:396-405
Micklem HS, Lennon JE, Amsell 10, Gray RA (1987) Minbers and dispersion
of repopulating cell clones in radiation chimeras as a function
of injected cell dose. Exp Hematol 15:251-257
Rosendaal M, Adam J (1984) Haemopoiesis by clonal succession? Blood
Cells 10:473- 485
Snodgrass R, Keller G ( 1987) Clonal fluctuation within the hematopoietic
system in mice reconstituted with retrovirus-infected cells EMBO
J 6:3955-3961
Williams DA, Lemischka IR Nathan DG, Mulligan RC (1984) Introduction
of new genetic material into pluripotent stem cells of the mouse
Nature 310:476-482
Abstract
Developmental fate of retrovirally marked hematopoietic stem cells
(HSC) critically depends on the use of pharmacological concentration
of growth factors during gene transfer procedure Cytokines (interleukin-6
plus stem cell factor) stimulated HSCs proliferate at least 4 months
after reconstitution. At this time hundred of hematopoietic clones
are exist simultaneously. Later as a result of clonal selection
only oligo-clonal hematopoiesis was detected. Vice verse, after
more physiological prestimulation of HSC on irradiated adherent
cell layer of long-term bone marrow culture no phase of polyclonal
hematopoiesis has been observed Hematopoiesis was according to clonal
succession model and replacing each other hematopoietic cell clones
were revealed The longevity of clone existence was not longer than
2-3 months The proliferative activity of CFU-S was higher in reconstituted
with small dose of bone marrow cells mice That could be connected
with enlargement of individual clone size in these animals The results
support the clonal succession model of hematopoiesis and incapacity
of primitive HSC to maintain itself The data demonstrate the possibility
of using this model for the sequential study of the clonal composition
of the hematopoietic system and primitive HSC developmental potential
|